Mohs surgery for the treatment of skin cancer a review of guidelines
Nine evidence-based guidelines were identified; two guidelines issued recommendations on basal cell carcinoma, four on squamous cell carcinoma, two on melanoma, and one on Merkel cell carcinoma. Mohs micrographic surgery (MMS) is recommended as a first-line option for high-risk primary or recurrent...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2019, March 20, 2019
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Nine evidence-based guidelines were identified; two guidelines issued recommendations on basal cell carcinoma, four on squamous cell carcinoma, two on melanoma, and one on Merkel cell carcinoma. Mohs micrographic surgery (MMS) is recommended as a first-line option for high-risk primary or recurrent basal cell carcinoma. For high-risk primary or recurrent squamous cell carcinoma, MMS may be considered as one of the options, especially where tissue preservation or margin controls are challenging, or when the tumour is at a critical anatomical site |
|---|---|
| Physical Description: | 1 PDF file (18 pages) illustration |